Share on StockTwits

Vitamin Shoppe (NYSE:VSI) Chairman Richard L. Markee sold 10,000 shares of Vitamin Shoppe stock in a transaction dated Monday, June 16th. The shares were sold at an average price of $45.00, for a total transaction of $450,000.00. Following the transaction, the chairman now directly owns 60,419 shares of the company’s stock, valued at approximately $2,718,855. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Vitamin Shoppe (NYSE:VSI) traded down 0.02% during mid-day trading on Wednesday, hitting $45.51. The stock had a trading volume of 308,086 shares. Vitamin Shoppe has a 1-year low of $39.92 and a 1-year high of $55.20. The stock has a 50-day moving average of $43.96 and a 200-day moving average of $46.57. The company has a market cap of $1.378 billion and a price-to-earnings ratio of 20.97.

Vitamin Shoppe (NYSE:VSI) last announced its earnings results on Wednesday, May 7th. The company reported $0.67 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.68 by $0.01. The company had revenue of $307.80 million for the quarter, compared to the consensus estimate of $302.82 million. During the same quarter last year, the company posted $0.72 earnings per share. Vitamin Shoppe’s revenue was up 10.3% compared to the same quarter last year. On average, analysts predict that Vitamin Shoppe will post $2.42 earnings per share for the current fiscal year.

VSI has been the subject of a number of recent research reports. Analysts at Bank of America upgraded shares of Vitamin Shoppe from an “underperform” rating to a “neutral” rating in a research note on Wednesday, June 4th. They now have a $47.00 price target on the stock. Separately, analysts at Barclays upgraded shares of Vitamin Shoppe from an “equal weight” rating to an “overweight” rating in a research note on Friday, May 9th. They now have a $51.00 price target on the stock, up previously from $49.00. Finally, analysts at Jefferies Group raised their price target on shares of Vitamin Shoppe from $45.00 to $48.00 in a research note on Friday, May 9th. Five equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. Vitamin Shoppe has an average rating of “Buy” and a consensus target price of $52.72.

Vitamin Shoppe, Inc is a specialty retailer and direct marketer of vitamins, minerals, herbs, specialty supplements, sports nutrition and other health and wellness products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.